NCT06762327 Ensartinib in the Treatment of ALK Positive or MET Exon 14 Skipping Anvanced Solid Tumors Excluded Lung Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06761417 A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults Status RECRUITING Phase PHASE2
NCT06755086 TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors Status NOT_YET_RECRUITING Phase N/A
NCT06736379 Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer Status RECRUITING Phase PHASE1
NCT06727812 Multicenter Phase I Study of HRS-6208 in Patients With Solid Tumors Status RECRUITING Phase PHASE1
NCT06710379 A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06710132 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) Status RECRUITING Phase PHASE1/PHASE2
NCT06651593 Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors Status RECRUITING Phase PHASE2
NCT06644755 First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06636435 A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer Status RECRUITING Phase PHASE1
NCT06621563 Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06553846 A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT06553157 Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy Status COMPLETED Phase PHASE1/PHASE2
NCT06536400 Phase I Study of HSK42360 in Solid Tumors With BRAF V600 Mutation Status RECRUITING Phase PHASE1
NCT06431594 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06410131 Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16 Status RECRUITING Phase PHASE1
NCT06390995 A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06386146 JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation Status RECRUITING Phase PHASE1/PHASE2
NCT06345001 A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers Status COMPLETED Phase PHASE1